Association of Herbal Tea and Follicle-Stimulating Hormone, Anthropometric Parameters, and Fasting Blood Glucose Levels Among Polycystic Ovarian Syndrome Women: A Systematic Review and Meta-Analysis of Clinical Trials

Overview

Journal Clin Nutr Res

Date 2024 Aug 21

PMID 39165287

Authors

Elahe Abbasi

Zahra Hajhashemy

Gholamreza Askari

Parvane Saneei

Affiliations

Soon will be listed here.

Abstract

This systematic review and meta-analysis of randomized controlled trials (RCTs) aimed to test our hypothesis that herbal tea may improve anthropometric parameters, metabolic factors, and hormone levels in women with polycystic ovarian syndrome (PCOS). A literature search was conducted on Information Sciences Institute, Medline (PubMed), Scopus, Embase, and Google Scholar, up to March 2023 without applying language or date restrictions. RCTs that assigned herbal tea vs. placebo on PCOS women and evaluated changes in anthropometric measurements, metabolic indices, or hormonal profiles were included. Six RCTs with 235 PCOS women (119 in the intervention and 116 in the control group) were included. Meta-analysis showed that herbal tea consumption led to significant decreases in weight (weighted mean difference [WMD], -2.02 kg; 95% confidence interval [CI], -3.25, -0.80), body mass index (BMI) (WMD, -0.88 kg/m; 95% CI, -1.47, -0.28) and fasting blood glucose (FBG) (WMD, -6.47 mg/dL; 95% CI, -8.49, -4.45), compared to the control group. Herbal tea supplementation has also significantly increased follicle-stimulating hormone (FSH) concentration (WMD, 0.56 IU/L; 95% CI, 0.17, 0.95). Meanwhile, the effect of herbal tea on the waist/hip ratio, hip circumference, waist circumference, body fat, fasting insulin, FBG/insulin ratio, luteinizing hormone, total testosterone, and dehydroepiandrosterone sulfate was not significant. Herbal tea might be a potential supplemental therapy to manage weight, BMI, FBG, and FSH in PCOS women. Further large randomized clinical trials are recommended to affirm these findings.

References

. ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome. Obstet Gynecol. 2018; 131(6):e157-e171. DOI: 10.1097/AOG.0000000000002656. View

Mulders A, Laven J, Eijkemans M, de Jong F, Themmen A, Fauser B . Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility. Hum Reprod. 2004; 19(9):2036-42. DOI: 10.1093/humrep/deh373. View

Grant P, Ramasamy S . An update on plant derived anti-androgens. Int J Endocrinol Metab. 2013; 10(2):497-502. PMC: 3693613. DOI: 10.5812/ijem.3644. View

Chan C, Koo M, Ng E, Tang O, Yeung W, Ho P . Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome--a randomized placebo-controlled trial. J Soc Gynecol Investig. 2005; 13(1):63-8. DOI: 10.1016/j.jsgi.2005.10.006. View

Chien Y, Chang C, Wu M, Chen C, Horng Y, Wu H . Effects of Curcumin on Glycemic Control and Lipid Profile in Polycystic Ovary Syndrome: Systematic Review with Meta-Analysis and Trial Sequential Analysis. Nutrients. 2021; 13(2). PMC: 7924860. DOI: 10.3390/nu13020684. View

Vernarelli J, Lambert J . Tea consumption is inversely associated with weight status and other markers for metabolic syndrome in US adults. Eur J Nutr. 2012; 52(3):1039-48. PMC: 3515715. DOI: 10.1007/s00394-012-0410-9. View

Chantre P, Lairon D . Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity. Phytomedicine. 2002; 9(1):3-8. DOI: 10.1078/0944-7113-00078. View

Dulloo A, Duret C, Rohrer D, Girardier L, Mensi N, Fathi M . Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr. 1999; 70(6):1040-5. DOI: 10.1093/ajcn/70.6.1040. View

Mombaini E, Jafarirad S, Husain D, Hossein Haghighizadeh M, Padfar P . The Impact of Green Tea Supplementation on Anthropometric Indices and Inflammatory Cytokines in Women with Polycystic Ovary Syndrome. Phytother Res. 2017; 31(5):747-754. DOI: 10.1002/ptr.5795. View

10.

Payab M, Hasani-Ranjbar S, Shahbal N, Qorbani M, AleTaha A, Haghi-Aminjan H . Effect of the herbal medicines in obesity and metabolic syndrome: A systematic review and meta-analysis of clinical trials. Phytother Res. 2019; 34(3):526-545. DOI: 10.1002/ptr.6547. View

11.

Johnston K, Sharp P, Clifford M, Morgan L . Dietary polyphenols decrease glucose uptake by human intestinal Caco-2 cells. FEBS Lett. 2005; 579(7):1653-7. DOI: 10.1016/j.febslet.2004.12.099. View

12.

Tehrani H, Allahdadian M, Zarre F, Ranjbar H, Allahdadian F . Effect of green tea on metabolic and hormonal aspect of polycystic ovarian syndrome in overweight and obese women suffering from polycystic ovarian syndrome: A clinical trial. J Educ Health Promot. 2017; 6:36. PMC: 5441188. DOI: 10.4103/jehp.jehp_67_15. View

13.

Raja-Khan N, Stener-Victorin E, Wu X, Legro R . The physiological basis of complementary and alternative medicines for polycystic ovary syndrome. Am J Physiol Endocrinol Metab. 2011; 301(1):E1-E10. PMC: 4459923. DOI: 10.1152/ajpendo.00667.2010. View

14.

Wellman P . Norepinephrine and the control of food intake. Nutrition. 2000; 16(10):837-42. DOI: 10.1016/s0899-9007(00)00415-9. View

15.

Navaratnarajah R, C Pillay O, Hardiman P . Polycystic ovary syndrome and endometrial cancer. Semin Reprod Med. 2008; 26(1):62-71. DOI: 10.1055/s-2007-992926. View

16.

Akdogan M, Tamer M, Cure E, Cumhur Cure M, Koroglu B, Delibas N . Effect of spearmint (Mentha spicata Labiatae) teas on androgen levels in women with hirsutism. Phytother Res. 2007; 21(5):444-7. DOI: 10.1002/ptr.2074. View

17.

Mansour-Ghanaei F, Hadi A, Pourmasoumi M, Joukar F, Golpour S, Najafgholizadeh A . Green tea as a safe alternative approach for nonalcoholic fatty liver treatment: A systematic review and meta-analysis of clinical trials. Phytother Res. 2018; 32(10):1876-1884. DOI: 10.1002/ptr.6130. View

18.

Liou T, Yang J, Hsieh C, Lee C, Hsu C, Hsu M . Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women. Fertil Steril. 2008; 92(6):1960-5. DOI: 10.1016/j.fertnstert.2008.09.003. View

19.

Kao Y, Hiipakka R, Liao S . Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology. 2000; 141(3):980-7. DOI: 10.1210/endo.141.3.7368. View

20.

HOEGER K . Obesity and weight loss in polycystic ovary syndrome. Obstet Gynecol Clin North Am. 2001; 28(1):85-97, vi-vii. DOI: 10.1016/s0889-8545(05)70187-x. View